Spatial and temporal tumor genomic heterogeneity in extramedullary multiple myeloma and solitary plasmacytoma with minimal marrow involvement

Basic Information

Funding Cycle : 2021-2022
Name : Urvi Shah
Type of Award : Career Development Award
Home Institution : Memorial Sloan Kettering Cancer Center, New York, NY
Host Institution : University of Miami/Sylvester Cancer Center


To test the hypothesis that plasmacytomas can represent spatial and temporal clonal escape events, featuring distinct myeloma-defining genomic events characteristic of active disease, through the following specific aims:
Aim 1. Compare genomic driver events in paired samples from patients with newly diagnosed solitary plasmacytoma (SP) with minimal marrow involvement versus newly diagnosed multiple myeloma (NDMM) to identify myeloma-defining events in the plasmacytoma.
Aim 2. Compare genomic events in paired samples at MM relapse versus NDMM to identify genomic events associated extramedullary localization and progression of the disease.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events